Evaluation of hepatocyte growth factor in patients with biliary atresia

Journal of Pediatric Surgery

Volumn 43, Issue 7, 2008, Pages 1333-1337

  Hsieh, Chih Sung ^a   Huang, Li Tung ^a   Lee, Shin Ye ^b   Huang, Chao Cheng ^b   Lee, Ching Lin ^a   Chuang, Jiin Haur ^a   Chen, Chao Long ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Biliary atresia; Hepatocyte growth factor; Liver cirrhosis

Indexed keywords

MESSENGER RNA; SCATTER FACTOR;

ARTICLE; BILE DUCT ATRESIA; CELL PROLIFERATION; COMMON BILE DUCT CYST; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIVER CELL; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PORTOENTEROSTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BILIARY ATRESIA; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; DISEASE PROGRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; INFANT; LIVER; LIVER TRANSPLANTATION; PORTOENTEROSTOMY, HEPATIC; RNA, MESSENGER;

EID: 47049085448     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2007.09.007     Document Type: Article

References (22)

1. Serinet M.O., Broue P., Jacquemin E., et al. Management of patients with biliary atresia in France: results of a decentralized policy 1986-2002. Hepatology 44 (2006) 75-84
2. Shneider B.L., Brown M.B., Haber B., et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 148 (2006) 467-474
3. Lai H.S., Chen W.J., Chen C.C., et al. Long-term prognosis and factors affecting biliary atresia from experience over a 25 years period. Chang Gung Med J 29 (2006) 234-239
4. Kosai K.I., Matsumoto K., Funakoshi H., et al. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30 (1999) 151-159
5. Tsubouchi H. Hepatocyte growth factor for liver disease. Hepatology 30 (1999) 333-334
6. Inoue H., Yokoyama F., Kita Y., et al. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Int J Mol Med 17 (2006) 857-864
7. Yoshikawa A., Kai do T., Seto S., et al. Hepatocyte growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic rats. J Surg Res 78 (1998) 54-59
8. Tsau Y.K., Chen C.H., Chang M.H., et al. Nephromegaly and elevated hepatocyte growth factor in children with biliary atresia. Am J Kidney Dis 29 (1997) 188-192
9. Vejchapipat P., Theamboonlers A., Chaokhonchai R., et al. Serum hepatocyte growth factor and clinical outcome in biliary atresia. J Pediatr Surg 39 (2004) 1045-1049
10. Uchida K., Inoue M., Otake K., et al. The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia. J Pediatr Surg 41 (2006) 1657-1662
11. Grizzle W.E., Myers R.B., Manne U., et al. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. In: Hanausek M., and Walaszek Z. (Eds). Methods in molecular medicine, tumor marker protocols vol 14 (1997), Humana Press Inc, Totowa, NJ 143-160
12. Matsuda Y., Matsumoto K., Yamada A., et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26 (1997) 81-89
13. Matsuda Y., Matsumoto K., Ichida T., et al. Hepatocyte growth factor suppresses the onset of cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 118 (1995) 643-649
14. Hata J., Ikeda E., Uno H., et al. Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR. J Histochem Cytochem 50 (2002) 1461-1468
15. Xia J.L., Dai C., Michalopoulos G.K., et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168 (2006) 1500-1512
16. Yasuda H., Imai E., Shiota A., et al. Antifibrogenic effect of a deletion variant of hepatocyte growth factor or liver fibrosis in rats. Hepatology 24 (1996) 636-642
17. Kim W.H., Matsumoto K., Bessho K., et al. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 166 (2005) 1017-1028
18. Schoedel K.E., Tyner V.Z., Kim T.H., et al. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Mod Pathol 16 (2003) 14-21
19. Shiota G., Okano J., Kawamura H., et al. Serum hepatocyte growth factor levels in liver diseases: clinical implication. Hepatology 21 (1995) 106-112
20. Liu Z., Sakamodo T., Ezure T., et al. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interaction between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology 28 (1998) 1260-1268
21. Funakoshi H., and Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 327 (2003) 1-23
22. Schirmacher P., Geerts A., Pietrangelo A., et al. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology 15 (1992) 5-11